Aerovate Therapeutics, Inc. (AVTE) Current Ratio % [USD] 2022 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aerovate Therapeutics, Inc. quarterly Current Ratio history and growth rate from 2022 to 2024.
  • Aerovate Therapeutics, Inc. Current Ratio for the quarter ending March 31, 2024 was 846 %, a 54.1% decline year-over-year.
Current Ratio, Quarterly (% [USD])
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 846 -997 -54.1% Mar 31, 2024
Q4 2023 950 -1.54 K -61.8% Dec 31, 2023
Q3 2023 1.17 K -2.25 K -65.8% Sep 30, 2023
Q2 2023 1.39 K -3.17 K -69.4% Jun 30, 2023
Q1 2023 1.84 K -1.97 K -51.7% Mar 31, 2023
Q4 2022 2.49 K Dec 31, 2022
Q3 2022 3.41 K Sep 30, 2022
Q2 2022 4.56 K Jun 30, 2022
Q1 2022 3.82 K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.